...
首页> 外文期刊>European Journal of Nuclear Medicine and Molecular Imaging >Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity Y-86- or Lu-177-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates
【24h】

Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity Y-86- or Lu-177-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates

机译:使用皮摩尔亲和力Y-86-或Lu-177-DOTA-Bn结合scFv C825 / GPA33 IgG双特异性免疫偶联物在小鼠中进行大肠癌异种移植的靶向治疗的放射疗法

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose GPA33 is a colorectal cancer (CRC) antigen with unique retention properties after huA33-mediated tumor targeting. We tested a pretargeted radioimmunotherapy (PRIT) approach for CRC using a tetravalent bispecific antibody with dual specificity for GPA33 tumor antigen and DOTA-Bn-(radiolanthanide metal) complex.
机译:目的GPA33是在huA33介导的肿瘤靶向后具有独特保留特性的结直肠癌(CRC)抗原。我们测试了针对CRC的预靶向放射免疫疗法(PRIT)方法,该方法使用对GPA33肿瘤抗原和DOTA-Bn-(放射性金刚烷金属)复合物具有双重特异性的四价双特异性抗体。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号